What is the current price of MOLN.SW stock?

MOLN.SW stock trades at **CHF 3.07** on SIX. Day range is **CHF 3.06–3.10** with volume **18,270** versus average **41,241**. Prices update in real time on trading platforms.

How does Meyka AI rate MOLN.SW stock?

Meyka AI rates MOLN.SW with a score out of 100 at **61.09**, grade **B**, and a **HOLD** suggestion. The grade combines benchmark and sector comparisons, financial growth, metrics, forecasts, and analyst consensus.

What forecast does Meyka AI give for MOLN.SW stock?

Meyka AI's forecast model projects a yearly price of **CHF 2.78**, implying **-9.29%** versus **CHF 3.07** today. Forecasts are model-based projections and not guarantees.

What are the main catalysts for MOLN.SW stock?

Main catalysts are clinical trial readouts, licensing deals with partners like Novartis, and the earnings report on **12 Mar 2026**. Positive milestones may drive larger moves given the company’s small market cap.

CH Stocks

Wainwright buy lifts MOLN.SW Molecular Partners AG (SIX) 30 Jan 2026: pre-market interest

ByHuzaifa Zahoor January 30, 2026

A new analyst buy call has pushed interest in the MOLN.SW stock ahead of the Swiss pre-market session. Molecular Partners AG (MOLN.SW) trades at CHF 3.07 on SIX with volume 18,270 and a 50-day average of CHF 3.29. The note from H.C. Wainwright and the company pipeline drove the move, while liquidity and trial timelines will set short-term direction.